Tactogen
About this raise
Tactogen, with a valuation of $80 million, is raising funds on Wefunder. The company is developing entactogen molecules for effective prescription mental health. Entactogens are MDMA-like molecules that help people embody a better version of themselves and let them keep their fears and self-criticism aside to think clearly about their lives. The aim of Tactogen is to bring the emotional benefits of MDMA to people while warding off their unwanted and off-target effects. Matthew Baggott founded Tactogen in February 2020. The current crowdfunding campaign has a minimum target of $50,000 and a maximum target of $5 million. The campaign proceeds will be used for safety and toxicity studies for leading molecules, Phase 1 clinical trial development, and community initiatives.
Investment Overview
Invested : $94,542
Deal Terms
Total Commitments
- Platform
- Wefunder
- Start Date
- 11/11/2022
- Close Date
- 01/31/2023
$50,000
$5,000,000
$100
SAFE
Growth Stage
RegCF
$80,000,000
15%
Company & Team
Company
- Year Founded
- 2020
- Industry
- Healthcare & Pharmaceuticals
- Tech Sector
- Distribution Model
- B2B/B2C
- Margin
- Medium
- Capital Intensity
- High
Upgrade to gain access
-
$12.50 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
Kingscrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual
Edge
Ratings 
Company Funding & Growth
Funding history
- Total Prior Capital Raised
- $6,486,070
- VC Backed?
- Yes
| Close Date | Platform | Valuation | Total Raised | Security Type | Status | Reg Type |
|---|---|---|---|---|---|---|
| 01/31/2023 | Wefunder | $80,000,000 | $94,542 | SAFE | Funded | RegCF |